Patients with hypertrophic cardiomyopathy (HCM) exhibit a variable phenotype with
ventricular hypertrophy as the cardinal manifestation and left ventricular (LV) outflow tract …

Objective This investigation analyzed clinical characteristics of patients with hypertrophic
cardiomyopathy (HCM) and latent left ventricular outflow tract (LVOT) and outcomes …

Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular
hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or …

In hypertrophic cardiomyopathy, multimodality imaging is crucial to confirm diagnosis,
assess for presence and mechanism of left ventricular outflow tract obstruction, and risk …

OBJECTIVES A novel transapical beating-heart septal myectomy (TA-BSM) procedure was
performed for patients with latent obstruction through the left intercostal incision and without …

Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a heterogeneous disease
with different clinical presentations, albeit producing similar dismal long-term outcomes if left …

Patients with hypertrophic cardiomyopathy (HC) are at increased risk of sudden cardiac
death. Abnormalities in myocardial blood flow (MBF) detected by positron emission …

Background Cardiopulmonary exercise test (CPET) is indicated as part of the assessment in
hypertrophic cardiomyopathy (HCM) patients and stress echocardiography is often used to …

Risk stratification for sudden cardiac death (SCD) is essential in the management of
hypertrophic cardiomyopathy (HC). The 2014 European Society of Cardiology SCD risk …

Background Atrial fibrillation (AF) is a common complication in patients with hypertrophic
cardiomyopathy (HCM) and may contribute to high cardiovascular morbidity and mortality …